Italy Blood Collection Devices Market Overview, 2031

Key Insights

• According to the research report, "Italy Blood Collection Devices Market Outlook, 2031," published by Bonafide Research, the Italy Blood Collection Devices Market is anticipated to grow at more than 7.18% CAGR from 2026 to 2031.
• Italy's healthcare system (Servizio Sanitario Nazionale – SSN) operates on a decentralized, regional basis (e.g., Lombardy, Lazio, Emilia-Romagna), driving procurement through regional central purchasing bodies (Centrali di Committenza). This structure enforces strict, high-volume tenders for safety-engineered blood collection consumables (evacuated tubes, closed safety butterfly sets, and lancets) to standardize pre-analytical workflows and lower acquisition costs across local health authorities.
• Italy has one of the oldest populations globally, putting immense operational strain on regional acute-care hospitals. To relieve overburdened phlebotomy clinics, Italian healthcare providers are adopting capillary microsampling devices, including upper-arm push-button units and volumetric dried blood spot (DBS) tools. These technologies facilitate decentralized, home-based therapeutic drug monitoring and routine chronic disease screening integrated into regional telemedicine frameworks.
• A major innovation evaluated across European clinical research centers, including leading Italian university hospitals, is the deployment of autonomous AI-guided robotic blood-drawing platforms (such as Vitestro’s Aletta system). Utilizing near-infrared vein illumination and 3D ultrasound guidance, these automated systems complete routine venipunctures without human intervention, addressing phlebotomy workforce shortages and reducing specimen pre-analytical hemolysis rates.

Market Outlook

• Italian pathology laboratories and private diagnostic chains (such as Lifebrain and SYNLAB Italy) will expand integration of pre-barcoded vacuum tubes, bedside automated tube-labeling units, and digital sample tracking linked to Laboratory Information Management Systems (LIMS) to ensure full chain-of-custody traceability. Aligned with EU directives and Italy’s National Recovery and Resilience Plan (PNRR) sustainability goals, regional health procurement tenders will increasingly mandate eco-friendly collection hardware including bio-based polymers, lightweight collection tubes, and recyclable secondary packaging.
• Major device suppliers operating in Italy include Becton, Dickinson and Company (BD Italia), Greiner Bio-One Italia, Sarstedt S.r.l., Terumo Blood and Cell Technologies, and Fresenius Kabi Italia, operating alongside key governing organizations such as CNS (Centro Nazionale Sangue), AVIS (Associazione Volontari Italiani del Sangue), Confindustria Dispositivi Medici, and the ISS (Istituto Superiore di Sanità).

Market Dynamics

Driver: Demographic aging strain and high burden of chronic cardiovascular/metabolic illnesses
Italy has one of the world's oldest population demographics, leading to a high prevalence of chronic conditions such as type-2 diabetes, oncology, and cardiovascular diseases. Continuous health monitoring and routine diagnostic testing across Italy's public healthcare networks (Servizio Sanitario Nazionale - SSN) create a steady, non-discretionary baseline demand for single-use venous and capillary blood collection hardware such as vacuum tubes, safety-engineered butterfly needles, and lancets to perform routine diagnostic panels.
Challenge: Regional procurement bureaucracy and payback ceiling
Medical device suppliers in Italy face severe operational friction due to decentralized regional procurement frameworks (Centrali di Committenza) and the enforcement of the controversial Payback Dispositivi Medici law. This legislative mechanism forces medical device companies to refund a percentage of regional healthcare budget overspends to local authorities, severely squeezing profit margins on commodity consumables like collection tubes and needles, while delaying payment cycles and long-term supply contract renewals.
Trend: Rapid shift toward smart phlebotomy, pre-barcoding, and LIMS integration
To reduce pre-analytical lab errors and lower operational costs in regional reference laboratories, Italian diagnostic centers and hospital networks are rapidly adopting smart, digitalized phlebotomy workflows. This trend emphasizes pre-barcoded vacuum collection tubes, automated point-of-draw tube labeling equipment, and digital sample tracking linked directly to Laboratory Information Management Systems (LIMS), ensuring complete sample traceability and reduced pre-analytical sample hemolysis rates.

Segment Analysis

Italy Blood Collection Devices Market By Product Type
• Blood collection tubes in Italy are increasingly positioned as critical components of the pre-analytical laboratory process, with tube chemistry, anticoagulants, specimen stability, identification, and compatibility with automated laboratory platforms influencing procurement decisions. Italian laboratories operate within a healthcare environment that places strong emphasis on standardized procedures and quality assurance, making consistency between collection sites and downstream laboratories particularly important. Tubes that support automated sorting, centrifugation, aliquoting, and analyzer workflows can offer advantages over products that require additional manual handling.
• Needles and syringes in Italy are increasingly differentiated through occupational safety, ergonomic design, specimen-quality performance, and compatibility with standardized collection systems. Safety-engineered needles can reduce opportunities for blood exposure during and after venipuncture, while specialized syringes remain relevant for applications such as blood-gas sampling and other controlled blood draws. The category is also influenced by efforts to reduce pre-analytical problems such as hemolysis, insufficient sample volume, contamination, or inappropriate specimen handling.
• Blood bags have a particularly strategic role in Italy because the national transfusion system integrates donor collection, component preparation, qualification, distribution, transfusion medicine, and plasma collection for industrial fractionation. Italy's national medical-device classification explicitly identifies blood-collection bags, transfer bags, component-sampling bags, filtration systems, and specialized bags for platelet and red-cell processing. This reflects a market in which the blood bag is part of an integrated component-manufacturing process rather than merely a container.
• Blood collection systems and monitors are particularly relevant to Italy's organized transfusion and apheresis infrastructure, where collection increasingly functions as part of a controlled blood-component production workflow. These systems can support monitoring of collection parameters, anticoagulant management, blood flow, component separation, and procedure documentation. Italy's national device classification separately recognizes apheresis collection devices for plasma, platelets, leukocytes, and multiple blood components, demonstrating the specialized nature of this segment.
• Lancets are increasingly associated with capillary blood sampling, point-of-care testing, diabetes monitoring, pediatric sampling, community healthcare, and decentralized diagnostics. In Italy, product differentiation centers on controlled penetration, patient comfort, sterile single-use construction, sharps safety, and ease of operation. Their relevance increases when healthcare providers need to obtain a small specimen without performing conventional venipuncture.
• Others category includes micro-collection devices, capillary sampling products, specimen-transfer accessories, adapters, blood-draw accessories, and specialized collection components. Italy's national device classification provides a particularly broad framework for specialized blood-related products, including component-sampling bags, aliquoting kits, filtration products, apheresis equipment, and devices used in platelet-derived preparations. This makes the category more technologically diverse than a conventional residual segment.



Italy Blood Collection Devices Market By End-User
• Hospitals and ambulatory surgical centres require blood collection products across emergency care, inpatient diagnostics, surgery, intensive care, outpatient procedures, and transfusion medicine. A distinctive feature of Italy is the interaction between hospital-based clinical services and regional healthcare organization, creating demand for products that can be standardized while accommodating different facility workflows. Hospitals increasingly prioritize devices that reduce handling, support infection prevention, integrate with laboratory and transfusion systems, and maintain specimen traceability.
• Diagnostics and pathology laboratories place strong emphasis on specimen integrity because the collection process directly influences downstream analytical reliability. Italian laboratory workflows increasingly favor standardized tubes, reliable patient/specimen identification, consistent collection procedures, and devices compatible with automated sample-processing platforms. The importance of quality governance is reinforced by Italy's broader national clinical-guideline and healthcare-quality framework.
• Blood banks and transfusion services have one of the most specialized collection-device requirements in Italy because they are directly involved in donor management, blood collection, component production, qualification, storage, distribution, transfusion support, and haemovigilance. The national transfusion system is explicitly structured around uniform quality and safety requirements, with regional accreditation and coordinated national oversight. This creates strong demand for validated blood bags, collection sets, apheresis systems, component-processing equipment, and monitoring technologies.
• Other end users include physician practices, outpatient diagnostic centres, community healthcare facilities, research organizations, occupational-health services, and point-of-care testing environments. Their requirements generally emphasize ease of use, portability, small-volume sampling, rapid collection, and reduced specimen handling. Lancets, capillary collection devices, compact blood-draw systems, and specialized accessories are particularly suited to these environments.

Italy Blood Collection Devices Market By Application
• Diagnostic blood collection in Italy is strongly driven by the need to preserve specimen quality from patient identification and collection through laboratory analysis. Tube chemistry, anticoagulation, specimen volume, contamination prevention, transport stability, and compatibility with automated laboratory platforms are therefore important product characteristics. Increasing laboratory automation makes standardized collection products particularly valuable because inconsistent tube dimensions, labeling, or sample conditions can disrupt automated workflows.
• Therapeutic blood collection differs from diagnostic collection because the collected blood or blood component becomes part of a treatment pathway. It encompasses donor blood collection, production of red cells, platelets and plasma, apheresis, therapeutic plasma procedures, and preparation of blood-derived products. Italy's transfusion system explicitly covers both transfusion medicine and production activities, including plasma intended for industrial production of plasma-derived medicines.

Italy Blood Collection Devices Market By Method
• Manual blood collection remains fundamental in Italy because venipuncture requires clinical assessment, patient identification, vein selection, appropriate device choice, and adaptation to individual circumstances. It remains particularly important in routine hospital diagnostics, outpatient collection, primary care, and situations where automated collection technology is unnecessary. Product development is therefore focused on improving manual collection through safety-engineered needles, ergonomic holders, standardized tubes, closed collection systems, and accessories that reduce exposure and pre-analytical errors.
• Automated blood collection is most significant in Italy where collection is integrated with apheresis, component separation, and specialized transfusion workflows. Automated systems can regulate collection parameters, anticoagulant delivery, component separation, flow conditions, and procedure monitoring while reducing continuous manual intervention. Italy's national device classification explicitly distinguishes several forms of apheresis collection, including systems for plasma, platelets, leukocytes, and multiple components, highlighting the breadth of automated and semi-automated applications.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Blood Collection Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Blood Collection Tubes
• Needles & Syringes
• Blood Bags
• Blood Collection Systems/Monitors
• Lancets
• Others

By End-User
• Hospitals and ASCs
• Diagnostics and Pathology Laboratories
• Blood Banks
• Others

By Application
• Diagnostic Application
• Therapeutic Application

By Method
• Manual
• Automated